Learning Objectives:

1) To understand who are the appropriate patients to receive anti-amyloid antibodies;

2) to understand the benefits of anti-amyloid therapy; and

3) to appreciate the risks involved with anti-amyloid therapy

Session date: 
10/25/2024 - 12:00pm to 1:00pm CDT
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Participation

Please login or create an account to proceed.
Speaker Name: 
Dr. David Knopman